Dynamic Technology Lab Private Ltd Purchases Shares of 28,030 Bruker Corporation $BRKR

Key Points

• Dynamic Technology Lab Private Ltd acquired 28,030 shares of Bruker Corporation during the first quarter, valuing their purchase at approximately $1,170,000.
• Bruker recently reported a 0.32 EPS for the last quarter, missing the consensus estimate of $0.33, with revenues of $797.40 million down 0.4% year-over-year.
• The company declared a quarterly dividend of $0.05 per share, with an ex-dividend date of September 23rd, resulting in a 0.6% yield for shareholders.

Dynamic Technology Lab Private Ltd acquired a new stake in Bruker Corporation (NASDAQ:BRKR - Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 28,030 shares of the medical research company's stock, valued at approximately $1,170,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in BRKR. Pinnacle Bancorp Inc. acquired a new position in shares of Bruker in the 1st quarter valued at about $29,000. Allworth Financial LP increased its position in Bruker by 92.4% in the 1st quarter. Allworth Financial LP now owns 758 shares of the medical research company's stock valued at $30,000 after buying an additional 364 shares in the last quarter. Caitong International Asset Management Co. Ltd increased its position in Bruker by 1,354.5% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 800 shares of the medical research company's stock valued at $33,000 after buying an additional 745 shares in the last quarter. Annis Gardner Whiting Capital Advisors LLC bought a new stake in Bruker in the 1st quarter valued at about $42,000. Finally, MassMutual Private Wealth & Trust FSB increased its position in Bruker by 274.9% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 1,091 shares of the medical research company's stock valued at $46,000 after buying an additional 800 shares in the last quarter. 79.52% of the stock is owned by institutional investors and hedge funds.

Bruker Price Performance

Shares of BRKR stock traded down $1.03 on Friday, reaching $31.04. The company's stock had a trading volume of 1,923,967 shares, compared to its average volume of 2,669,418. The company has a quick ratio of 0.70, a current ratio of 1.61 and a debt-to-equity ratio of 1.31. Bruker Corporation has a 12-month low of $28.53 and a 12-month high of $72.94. The company has a market capitalization of $4.71 billion, a P/E ratio of 59.91, a PEG ratio of 4.23 and a beta of 1.21. The stock's 50 day simple moving average is $36.25 and its 200-day simple moving average is $39.11.

Bruker (NASDAQ:BRKR - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The medical research company reported $0.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.33 by ($0.01). Bruker had a return on equity of 17.89% and a net margin of 2.31%.The business had revenue of $797.40 million during the quarter, compared to analysts' expectations of $811.17 million. During the same quarter last year, the business posted $0.52 EPS. The company's quarterly revenue was down .4% on a year-over-year basis. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. As a group, equities analysts predict that Bruker Corporation will post 2.69 earnings per share for the current fiscal year.

Bruker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 3rd. Investors of record on Tuesday, September 23rd will be given a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Tuesday, September 23rd. Bruker's dividend payout ratio (DPR) is 38.46%.

Analysts Set New Price Targets

A number of analysts recently commented on BRKR shares. Stifel Nicolaus set a $40.00 target price on Bruker and gave the company a "hold" rating in a research report on Tuesday, August 5th. Citigroup reduced their target price on Bruker from $40.00 to $38.00 and set a "neutral" rating for the company in a report on Monday, August 4th. Wells Fargo & Company reduced their price objective on Bruker from $60.00 to $50.00 and set an "overweight" rating for the company in a report on Tuesday, August 5th. Bank of America reduced their price objective on Bruker from $61.00 to $50.00 and set a "buy" rating for the company in a report on Thursday, June 26th. Finally, Jefferies Financial Group set a $60.00 price objective on Bruker and gave the company a "buy" rating in a report on Monday, August 4th. Five equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average price target of $51.30.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.